| answer text |
<p>Whilst a detailed assessment is not yet available, it is likely that a combination
of factors has contributed to the Office of National Statistics measure of excess
mortality, including high flu prevalence, the ongoing challenges of COVID-19 and health
conditions such as heart disease and diabetes.</p><p>We are taking steps to help reduce
excess deaths, including those which involve COVID-19. Vaccines remain the first line
of defence against COVID-19. Antivirals and other treatments provide a necessary additional
line of defence by playing a crucial role in protecting patients who become infected
with COVID-19, particularly those who for whom the vaccine may be less effective such
as the immunosuppressed. We are preparing for variants of COVID-19 and respiratory
challenges, with an integrated COVID-19 booster and flu vaccination programme, minimising
hospital admissions from both viruses. This winter, it is vital that eligible people
get their booster jab and their flu jab to protect themselves, their loved ones and
the National Health Service.</p><p>We are also taking action to reduce excess deaths
due to other factors. The NHS has published a delivery plan setting out a clear vision
for how the NHS will recover and expand elective services over the next three years.
The plan commits the NHS to deliver nine million additional treatments and diagnostic
procedures over the next three years and around 30 percent more elective activity
than it was doing before the pandemic by 2024/25. Through the pathway improvement
programme, we will create extra capacity for elective care and improve patient health
outcomes.</p><p>We are making progress in restoring services for preventable conditions
such as cardiovascular disease (CVD). Based on the current rate of recovery, we expect
NHS Health Check delivery, a core part of our CVD prevention pathway, to return to
pre-pandemic levels by June 2023. The Department continues to work closely with partners
to consider what more can be done to improve the prevention, detection, diagnosis
and management of CVD.</p><p> </p><p> </p>
|
|
